Zoledronic Acid

ArtNr	HY-13777-500mg
Hersteller	MedChem Express
CAS-Nr.	118072-93-8
Menge	500 mg
Quantity options	100 mg 10 mM/1 mL 10 mM/1 mL 1 ea 200 mg 500 mg 50 mg
Kategorie	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Breast Cancer Lymphatic System Cancer
Typ	Inhibitors
Specific against	other
Purity	99.21
Citations	[1]Lianwei Wang, et al. Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review. BMC Cancer. 2020; 20: 1059.\|[2]Hyung Joon Kim, et al. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis. Int J Mol Sci. 2019 Mar; 20(6): 1467.\|[3]Xiao-Lin Huang, et al. Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways. Int J Mol Med. 2019 Aug;44(2):582-592.\|[4]XIN HUANG, et al. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol Med Rep. 2016 Jan; 13(1): 613-622.\|[5]Samantha Pozzi, et al. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res. 2009 Sep 15;15(18):5829-39.\|[6]Shea GKH, et al. Oral Zoledronic acid bisphosphonate for the treatment of chronic low back pain with associated Modic changes: A pilot randomized controlled trial. J Orthop Res. 2022 Feb 23. ACS Nano. 2023 Jul 10.\|Appl Biochem Biotechnol. 2024 Mar 25.\|Bone. 2024 Aug 3:117222.\|Commun Biol. 2024 Nov 9;7(1):1476.\|Eur J Med Chem. 2024 Dec 5.\|Int Immunopharmacol. September 2022, 109030.\|J Dent Sci. 2024 May 4.\|JCI Insight. 2025 Jan 30:e184468.\|Med Oncol. 2023 Apr 10;40(5):141.\|Nat Commun. 2024 Mar 21;15(1):2529.\|Oxid Med Cell Longev. 2021 Mar 31.\|Cell Rep Methods. 2023 Oct 23;3(10):100599.\|Dis Markers. 2021 Oct 15;2021:5838582.\|Gut Microbes. 2023 Dec;15(2):2249143.
Smiles	OC(P(O)(O)=O)(P(O)(O)=O)CN1C=CN=C1
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Zoledronate,CGP 42446,CGP42446A,ZOL 446
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Type	Reference compound
Manufacturer - Applications	Cancer-programmed cell death
Manufacturer - Targets	Apoptosis; Autophagy; Bacterial
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, stored under nitrogen)
Molecular Weight	272.09
Product Description	Zoledronic Acid (Zoledronate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic Acid inhibits the differentiation and apoptosis of osteoclasts. Zoledronic Acid also has anti-cancer effects[1].
Manufacturer - Research Area	Cancer; Metabolic Disease
Solubility	H2O: 4.17 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturer - Pathway	Anti-infection; Apoptosis; Autophagy
Clinical information	Launched

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

HY-13777-500mg-safety-datasheet.pdf